✦ LIBER ✦

Pharmacokinetics and Safety in Rhesus Monkeys of a Monoclonal Antibody-GDNF Fusion Protein for Targeted Blood-Brain Barrier Delivery

✍ Scribed by William M. Pardridge; Ruben J. Boado

Publisher: Springer US
Year: 2009
Tongue: English
Weight: 210 KB
Volume: 26
Category: Article
ISSN: 0724-8741
DOI: 10.1007/s11095-009-9939-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genetic engineering of a lysosomal enzym

Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood-brain barrier

✍ Ruben J. Boado; Yun Zhang; Yufeng Zhang; Chun-fang Xia; Yuntao Wang; William M. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB 👁 2 views

## Abstract Mucopolysaccharidosis Type I, Hurler's Syndrome, is a lysosomal storage disorder that affects the brain. The missing enzyme, α‐L‐iduronidase (IDUA), does not cross the blood‐brain barrier (BBB). To enable BBB transport of the enzyme, human IDUA was fused to the carboxyl terminus of the

Engineering and expression of a chimeric

Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood–brain barrier delivery in the mouse

✍ Ruben J. Boado; Yun Zhang; Yuntao Wang; William M. Pardridge 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 2 views

## Abstract Protein therapeutics may be delivered across the blood–brain barrier (BBB) by genetic fusion to a BBB molecular Trojan horse. The latter is an endogenous peptide or a peptidomimetic monoclonal antibody (MAb) against a BBB receptor, such as the insulin receptor or the transferrin recepto